154 related articles for article (PubMed ID: 34128470)
1. Reduced glucose-induced first-phase insulin release is a danger signal that predicts diabetes.
Weir GC; Bonner-Weir S
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 34128470
[TBL] [Abstract][Full Text] [Related]
2. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
[TBL] [Abstract][Full Text] [Related]
3. Assessment of β Cell Mass and Function by AIRmax and Intravenous Glucose in High-Risk Subjects for Type 1 Diabetes.
Hao W; Woodwyk A; Beam C; Bahnson HT; Palmer JP; Greenbaum CJ
J Clin Endocrinol Metab; 2017 Dec; 102(12):4428-4434. PubMed ID: 29040630
[TBL] [Abstract][Full Text] [Related]
4. Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Sosenko JM; Skyler JS; Beam CA; Krischer JP; Greenbaum CJ; Mahon J; Rafkin LE; Matheson D; Herold KC; Palmer JP;
Diabetes; 2013 Dec; 62(12):4179-83. PubMed ID: 23863814
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance is a risk factor for progression to type 1 diabetes.
Fourlanos S; Narendran P; Byrnes GB; Colman PG; Harrison LC
Diabetologia; 2004 Oct; 47(10):1661-7. PubMed ID: 15480539
[TBL] [Abstract][Full Text] [Related]
6. No Correlation of Pancreatic Fat and β-Cell Function in Young Women With and Without a History of Gestational Diabetes.
Popp D; Aertsen S; Luetke-Daldrup C; Coppenrath E; Hetterich H; Saam T; Rottenkolber M; Seissler J; Lechner A; Sommer NN
J Clin Endocrinol Metab; 2018 Sep; 103(9):3260-3266. PubMed ID: 29947782
[TBL] [Abstract][Full Text] [Related]
7. Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes.
Baidal DA; Warnock M; Xu P; Geyer S; Marks JB; Moran A; Sosenko J; Evans-Molina C
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3273-e3280. PubMed ID: 35524749
[TBL] [Abstract][Full Text] [Related]
8. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
9. Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes.
Ize-Ludlow D; Lightfoot YL; Parker M; Xue S; Wasserfall C; Haller MJ; Schatz D; Becker DJ; Atkinson MA; Mathews CE
Diabetes; 2011 Aug; 60(8):2086-91. PubMed ID: 21659497
[TBL] [Abstract][Full Text] [Related]
10. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets.
Song SH; Rhodes CJ; Veldhuis JD; Butler PC
Endocrinology; 2003 Aug; 144(8):3399-405. PubMed ID: 12865318
[TBL] [Abstract][Full Text] [Related]
11. First phase insulin release and glucose tolerance in children with Fanconi anemia after hematopoietic cell transplantation.
Polgreen LE; Thomas W; MacMillan ML; Wagner JE; Moran A; Petryk A
Pediatr Blood Cancer; 2009 Aug; 53(2):191-6. PubMed ID: 19353625
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes.
Siewko K; Popławska-Kita A; Telejko B; Maciulewski R; Zielińska A; Nikołajuk A; Górska M; Szelachowska M
J Diabetes Complications; 2013; 27(6):593-6. PubMed ID: 23890682
[TBL] [Abstract][Full Text] [Related]
13. Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype.
Street ME; Spaggiari C; Ziveri MA; Rossi M; Volta C; Viani I; Grzincich GL; Sartori C; Zanzucchi M; Raia V; Terzi C; Pisi G; Zanetti E; Boguszewski MC; Kamoi TO; Bernasconi S
J Endocrinol Invest; 2012 Mar; 35(3):246-53. PubMed ID: 21483232
[TBL] [Abstract][Full Text] [Related]
14. Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes.
Son J; Accili D
Exp Mol Med; 2023 Aug; 55(8):1652-1658. PubMed ID: 37524865
[TBL] [Abstract][Full Text] [Related]
15. Effect of partial pancreatectomy on beta-cell mass in the remnant pancreas of Wistar fatty rats.
Ogino T; Zhu M; Murakami T; Kuwajima M; Shima K
J Med Invest; 1998 Aug; 45(1-4):103-10. PubMed ID: 9864970
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of the anti-β-cell dedifferentiation mechanism of a modified Da Chaihu Decoction by an integrative approach of network pharmacology and experimental verification.
Chen H; Guo J; Cai Y; Zhang C; Wei F; Sun H; Cheng C; Liu W; He Z
J Ethnopharmacol; 2024 Mar; 321():117481. PubMed ID: 38007164
[TBL] [Abstract][Full Text] [Related]
17. A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes.
Parilla JH; Willard JR; Barrow BM; Zraika S
J Diabetes Res; 2018; 2018():6106051. PubMed ID: 29854823
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans.
Meier JJ; Breuer TG; Bonadonna RC; Tannapfel A; Uhl W; Schmidt WE; Schrader H; Menge BA
Diabetologia; 2012 May; 55(5):1346-54. PubMed ID: 22286529
[TBL] [Abstract][Full Text] [Related]
19. Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation.
Ravindran VK; Moore RH; Dunseath G; Luzio SD; Owens DR; Baboolal K
Transplantation; 2009 Jun; 87(12):1870-6. PubMed ID: 19543067
[TBL] [Abstract][Full Text] [Related]
20. Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes.
Mezza T; Ferraro PM; Di Giuseppe G; Moffa S; Cefalo CM; Cinti F; Impronta F; Capece U; Quero G; Pontecorvi A; Mari A; Alfieri S; Giaccari A
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33905373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
